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Abstract
Background: Asthma subtyping is a complex new field of study. Usually both etiological and outcome factors of
asthma have been used simultaneously for subtyping thus making the interpretation of the results difficult.
Identification of subtypes of asthma based on questionnaire data only will be useful for both treatment of asthma
and for research. Our objective was to identify asthma subtypes that capture both asthma control and severity
based on easily accessible variables.
Methods: We applied latent class analysis for the 1995 adult asthmatics, 692 men and 1303 women, of the
Northern Finnish Asthma Study (NoFAS). The classifying variables included use of asthma medication within the last
12 months, St. George’s Respiratory Questionnaire score, and asthma-related healthcare use within the last
12 months. Covariates adjusted for included COPD, allergic rhinitis/allergic eczema, BMI, age and sex. All
information was based on self-administered questionnaires.
Results: We identified four subtypes for women: Controlled, mild asthma (41% of participants); Partly controlled,
moderate asthma (24%); Uncontrolled asthma, unknown severity (26%), and Uncontrolled, severe asthma (9%). For men
we identified three subtypes: Controlled, mild asthma (31%); Poorly controlled asthma, unknown severity (53%); and
Partly controlled, severe asthma (17%). For almost 96% of the subjects this subtyping was accurate. The covariates
fitted in the model were based on clinical judgment and were good predictors of class membership.
Conclusions: Our results show that it is possible to form meaningful and accurate asthma subtypes based on
questionnaire data, and that separate classification should be applied for men and women.
Keywords: Asthma, Epidemiologic study, Latent class analysis, Asthma subtypes, Asthma control, Asthma severity,
Determinant, Risk factor
Background
Recently, multiple studies have applied clustering
methods to form asthma and wheeze subtypes [1–12].
In the previous literature, both etiological and out-
come factors of asthma have been included as classifi-
cation variables thus complicating further analyses on
e.g. risk factors of these subtypes. Also, subtypes
formed so far have included several clinical markers
not always available in primary health care or large
epidemiological studies. Thus, alternative subtyping is
needed to benefit these purposes. It has also been
commented, that the selection of variables in the pre-
vious studies has been wide and diverse [13]. In
clinical practice, the focus is usually on two aspects
of asthma: asthma severity and control.
Asthma control has been assessed by using self-
administered questionnaires, information on asthma
related healthcare use, or a priori grouping of individ-
uals [14–17]. Determinants of poor asthma control
identified previously include smoking [18], obesity
[19], concomitant diseases such as rhinitis and COPD
[20, 21], gender and age [22]. Poor asthma control af-
fects the quality of life of asthma patients and in-
creases the burden on the health care system [23, 24].
Asthma severity is another aspect applied for clinical
evaluation of asthma patients. It consists partly of
similar features as asthma control, but also has its’ in-
dependent dimension [25]. The ATS/ERS guidelines
described severity as “difficulty of controlling asthma
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with adequate treatment” [25]. At current state of
knowledge, the key questions for further research in-
clude 1) to what extent the interrelated aspects of
asthma control and severity can be separated, and 2)
how such separation should influence the treatment,
care, and prognosis of asthma patients.
To unravel the complex links and differences be-
tween asthma control and severity, we studied a total
of 1995 adult asthmatics from the Northern Finnish
Asthma Study by applying latent class analysis (LCA)
[26, 27]. The purpose of this study was to identify
subtypes of asthma based on questionnaire-data only,
among subjects already diagnosed to have asthma
based on the diagnostic criteria applied in Finland. In
order to enable further analyses on etiological factors
of the subtypes formed, we included only variables of
asthma manifestations in the classification. This en-
ables further risk-factor analyses by maintaining the
traditional idea of causality. The subtypes identified in
this study can be applied in studies investigating po-
tential role of environmental and behavioral factors in
determining the etiology and/or prognosis (of differ-
ent subtypes) of asthma. We addressed the following
questions: 1) Is it possible to identify asthma subtypes
which characterize the aspects of both asthma control
and asthma severity by applying questionnaire-based
information only; 2) When we assign a person to a
particular subtype, how certain can we be that he/she
truly belongs to that subtype; and 3) Do the subtypes
formed separately for men and women lead to a more
accurate classification? We also assessed 4) whether
the following characteristics: age, having COPD and/




The Northern Finnish Asthma Study (NoFAS) was initi-
ated in 2012 as a population-based cross-sectional study
of adults 17–73 years old who had asthma and who lived
in Northern Finland. The source population constituted of
subjects who had received the reimbursement right for
asthma medication, thus fulfilling the diagnostic criteria of
The Social Insurance Institution of Finland. The subjects
lived in The Oulu University Hospital District. We sent
two self-administrated questionnaires, the NoFAS respira-
tory questionnaire and the St George’s Respiratory Ques-
tionnaire to a random sample of 5000 subjects. A total of
2033 (40.7%) subjects responded. However, we excluded
respondents whose age and/or sex were unknown, so the
final study population included 1995 subjects (response
rate 40%). The data collection has been described in detail
in a previous study [28].
Variables used in the latent class analysis
We applied the following variables in the classification
of asthma: use of controller asthma medication, bron-
chodilators, oral corticosteroids, and/or antibiotics
during asthma exacerbations, and use of various health-
care services. All of these were inquired for the past
12 months. In addition, St. George’s Respiratory Ques-
tionnaire score in the past 4 weeks was applied.
Controller asthma medication was defined by the use
of inhaled corticosteroids (ICS) based on replies to the
questions: “During the previous year, have you used in-
haled steroids?” and/or “During the previous year, have
you used inhaled combination medication of corticoster-
oid and long-acting bronchodilator?” Inhaled broncho-
dilator (BD) use was defined by reply to the question:
“During the past year, have you used inhaled broncho-
dilator?” Oral corticosteroid use (OCS) was defined by
combining responses to two questions: “During the past
year, have you used oral corticosteroid tablets” and “Dur-
ing the past year, have you received prescription for oral
corticosteroids? If yes, how many courses?” Use of anti-
biotics for asthma exacerbations (AB) was defined based
on the following question: “During the last 12 months,
have you been prescribed antibiotics for asthma symp-
toms? If yes, how many courses?”
The St. George’s Respiratory Questionnaire total score
(SGTS) was calculated for the period of the past 4 weeks
and a categorical variable was created so that the base-
line level corresponded to the scores detected in healthy
subjects (i.e. 0–7 points) [29, 30]. SGTS has been re-
ported in previous studies to correlate with the duration
of asthma symptoms, the level of lung function mea-
surements, and the history of asthma exacerbations [31].
The healthcare use score (HCU) was defined as the sum
of the number of 1) sick leave days, 2) emergency room
visits, 3) hospital ward treatments, and 4) acute primary
health care visits, all due to asthma during the previous
12 months. Any health care visit because of acute
asthma exacerbation is nowadays rare in Finland, and
thus, high HCU scores were rare in our study population
[32]. The variables that were used in the analyses, and
their prevalence in the whole study population as well as
in men and women separately, are presented in Table 1.
Figure 1 displays the original variables in the question-
naires and the pathway that led to the finally defined
categorical variables of asthma control and severity.
Statistical methods
We applied latent class analysis (LCA), a method used to
classify observations into discrete, mutually exclusive clas-
ses on the basis of categorical manifest variables [26, 27].
We formed classes based on the whole study population
of 1995 subjects, and conducted subtypes analyses by gen-
der, as the test for measurement invariance implicated that
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this was advisable [27]. We then fitted the following covar-
iates into the model: diagnosis of COPD [21], allergic
rhinitis and/or allergic eczema [20], BMI [19], age, and
gender [22]. These covariates are known or suggested de-
terminants of poor asthma control and severity. We also
examined the clinical relevance of the identified subtypes
by calculating the likelihood of a person belonging to each
class, then selecting the best fit and applying this class to
each person. For each class, we calculated the mean likeli-
hood (min-max) at class-level. This mean likelihood de-
scribes how well, on average, a person fits to the class he/
she has the highest probability of belonging to. All ana-
lyses were conducted using the proc LCA –add-on in SAS
statistical software package (SAS, version 9.4, SAS Insti-
tute, Cary, NC) [26, 27].
Results
Table 1 presents the characteristics of the study population,
including both the variables that were used in latent class
forming the subtypes as well as the variables adjusted for as
covariates. Among the total of 1995 participants, two thirds
were women (65.3%). The age distribution was similar be-
tween men and women. As shown in Table 1, daily use of
controller asthma medication was common (78.1%). It is
noticeable that, except for the use of inhaled corticoste-
roids, men and women differed significantly with respect to
the use of asthma medications and of health care facilities,
even though the mean St. George’s score was similar
among the genders (Table 1). COPD diagnosis was more
common among men, whereas allergic diseases where
more common among women (Table 1).
Latent classes
We tested all the analyses by applying 2 to 6 classes, and
compared the fit-indices between the different models to
choose the best fitting classification (see Additional file 1:
Table S1) [33, 34]. When two or more models had similar
Table 1 Characteristics of the study population
Women Men Total population
N (%) N (%) N (%)
Total N 1303 (65.3) 692 (34.7) 1995 (100.0)
Age
<30 years 141 (10.8) 71 (10.3) 212 (10.6)
30–59 years 848 (65.1) 420 (61.7) 1268 (63.6)
≥60 years 314 (24.1) 201 (29.1) 515 (25.8)
Asthma controller medication usea
Not at all 80 (6.2) 48 (7.1) 128 (6.5)
Occasionally 200 (15.6) 103 (15.2) 303 (15.4)
Daily 1006 (78.2) 528 (77.8) 1534 (78.1)
Missing 17 13 30
Inhaled bronchodilatator use
Not at all 217 (17.2) 147 (22.0) 364 (18.9)
Occasionally 834 (66.0) 365 (54.7) 1199 (62.1)
Daily 213 (16.9) 155 (23.2) 368 (19.1)
Missing 39 25 64
Antibiotics for asthma exacerbations
0 prescription 970 (76.1) 590 (87.0) 1560 (79.9)
1 prescription 119 (9.3) 41 (6.1) 160 (8.2)
2 prescriptions 80 (6.3) 23 (3.4) 103 (5.3)
≥3 prescriptions 106 (8.1) 24 (3.5) 130 (6.7)
Missing 28 14 42
Oral corticosteroid use
0 prescriptions 893 (70.5) 558 (83.2) 1451 (74.9)
1–2 prescriptions 294 (23.2) 86 (12.8) 380 (19.6)
≥3 prescriptions 49 (3.9) 20 (3.0) 69 (3.6)
Daily use 30 (2.4) 7 (1.0) 37 (1.9)
Missing 37 21 58
St. George’s score 4 weeksb
0 to ≤7 300 (23.3) 180 (26.6) 480 (24.4)
>7 to ≤15 327 (25.4) 142 (21.0) 469 (23.9)
>15 to ≤27 331 (25.7) 166 (24.5) 497 (25.3)
>27 330 (25.6) 189 (27.9) 519 (26.4)
Missing 15 15 30
Health care facility use scorec
0 points 936 (73.0) 580 (84.2) 1516 (76.9)
1 point 107 (8.4) 34 (4.9) 141 (7.2)
2–3 points 183 (14.3) 56 (8.1) 239 (12.1)
≥4 points 56 (4.4) 19 (2.8) 75 (3.8)
Missing 21 3 24
COPD diagnosis
Yes 126 (10.0) 152 (23.2) 278 (14.5)
No 1135 (90.0) 504 (76.8) 1639 (85.5)
Missing 42 36 78
Table 1 Characteristics of the study population (Continued)
Allergic Rhinitis and/or Allergic Eczema
Yes 891 (68.9) 402 (59.4) 1293 (65.9)
No 394 (30.7) 275 (40.6) 669 (34.1)
Missing 18 15 33
BMI
≤ 25 504 (39.6) 216 (31.6) 720 (36.8)
>25 to ≤30 420 (33.0) 286 (41.8) 706 (36.1)
>30 350 (26.9) 170 (26.3) 532 (26.7)
Missing 29 8 37
aAsthma controller medication use includes both inhaled corticosteroids and
combination medication of inhaled corticosteroid and long-acting beta-agonist
bSt. George’s score range: 0–100
cHCU score formed as a combination of sick leave due to asthma, emergency
room visits for asthma, ward treatment periods for asthma, and acute primary
health care visits due to asthma
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fit-indices, we selected the amount of classes based on
clinical interpretability of the results. In order to elaborate
all possible combinations of control and severity, we cate-
gorized both into four levels: Fully controlled, Controlled,
Partly controlled, and Uncontrolled, and Mild, Moderate,
Unknown severity, and Severe.
Five classes combining asthma control and severity,
were formed for the whole study population: 1) Fully
controlled, mild asthma, 2) Partly controlled, mild
asthma, 3) Partly controlled, moderate asthma, 4) Un-
controlled, unknown severity, and 5) Uncontrolled, severe
asthma. Further analyses [33] indicated that applying
these five subtypes actually masked the differences be-
tween men and women, and thus, we further performed
sex-specific analyses. For the results of the five-class
model and the odds ratios for the predictive factors in
these analyses, please refer to the Additional file 1.
Four subtypes of asthma were identified for women
(Table 2). Among men the fit-indices were virtually iden-
tical for the two and three class model. In such cases, it
is recommendable to apply the classification that has
better clinical interpretability [26, 27]. Thus, we selected
the three class model. The subtypes identified for female
asthmatics were the following: 1) Controlled, mild
asthma, 2) Partly controlled, moderate asthma, 3) Un-
controlled asthma, unknown severity, and 4) Uncon-
trolled, severe asthma. The corresponding class
membership probabilities were 0.41 (0.35–0.46), 0.24
(0.19–0.28), 0.26 (0.20–0.32), and 0.09 (0.06–0.12), as
shown in Table 2.
Controlled, mild asthma was characterized by a prob-
ability of 0.14 (0.11–0.18) for using no ICS, in combin-
ation with the largest proportion of subjects needing no
bronchodilators, oral corticosteroids, or antibiotics, and
low use of health-care. As much as 0.48 (0.41–0.55) of
subjects in this subtype had a SGTS at the healthy per-
son’s level.
Among the Partly controlled, moderate asthma sub-
type most subjects (86%) used daily ICS (Table 2). In
addition, occasional BD use was in this group the high-
est of all classes (0.75, 0.69–0.82). They reported some
use of AB and OCS. Healthcare use was heterogeneous
among this class (Table 2). SGTS was mostly above the
healthy person’s level.
Uncontrolled asthma, unknown severity was described
by no health-care use, no AB or OCS, despite 0.49
(0.39–0.58) of the subjects had SGTS above 27 indicat-
ing poor control.
In the Uncontrolled, severe asthma subtype the pro-
portion of subjects using regular ICS was high at 0.94
(0.88–0.99) and also their use of daily bronchodilator
medication (BD) was high, as was their use of OCS and
AB as well as HCU. The majority of this subtype, i.e.
0.74 (0.63–0.85), had SGTS at the highest level indicat-
ing the poorest asthma control, while no subject was at
the healthy person’s level.
Fig. 1 Variable selection and the combination of variables used in forming latent classes. The upper level indicates the types of variables directly
derived from the questionnaire. The second level describes the combinations formed based on those variables and the levels used for latent class
forming. Altogether six variables were included in the classification
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Among men the identified subtypes differed substan-
tially from those identified among women, since the use
of asthma medications and healthcare services were low
despite of high SGTS indicating poor asthma control.
Use of BD was large among all asthma subtypes among
men. The subtypes identified were: 1) Controlled, mild
asthma, 2) Uncontrolled, unknown severity, and 3) Partly
controlled, severe asthma.
Controlled, mild asthma was characterized with
SGTS-scores at the healthy person’s level (0.59, 0.47–
0.72) indicating good asthma control, with no use of oral
medications or need for HCU (see Table 2).
For Uncontrolled, unknown severity the distribution of
SGTS was wide (Table 2). The probability of this group
using daily inhaled corticosteroids (ICS) was high at 0.82
(0.76–0.87), but using daily BD was also common. Des-
pite being poorly controlled, this class used OCS rarely
and reported low HCU (Table 2).
For Partly controlled, severe asthma the mean SGTS
was high (indicating poor control), although the percent-
age of daily users of ICS was high at 90%. Use of daily
BD was also high, and for this group, the use of OCS
and AB was also common suggesting severe asthma in
combination with high HCU scores (Table 2).
The best individual mean posterior probability for each
class among women and men are displayed in Table 3.
Only 37 women (2.84%) and 1 man (0.14%) had this best
posterior probability below 0.50. This indicates that if we
wish to apply these subtypes into clinical practice, taking
into account the gender of the patient is needed to make
this classification accurate and useful at the patient level.
Factors predicting latent class membership
In the LCA, the different subtypes of asthma are kept
fixed when covariates are included in the model. The
purpose of adding the covariates is to evaluate whether
individuals’ probability to belong to the studied asthma
subtypes changes. Thus, the posterior probabilities for
each individual need to be recalculated, while the item-
response probabilities do not. For each covariate, we cal-
culated the Likelihood X2-ratio P-value, which indicates
whether the corresponding variable is a good predictor
of class membership (see Table 4).
The results of the covariate analyses are displayed in
Table 4. For both genders Controlled, mild asthma was
used as the reference asthma category, thus this category
is not shown in Table 4. Among women, age over 60
was a strong predictor for Uncontrolled asthma with un-
known severity (OR: 22.25, 95% CI: 3.30–149.98). In
addition, subjects with the age of 30 to 59 years showed
a significantly elevated odds ratio for this subtype mem-
bership. In addition, subjects with BMI > 30 showed a
high odds ratio for this subtype among women (OR:
7.17, 95% CI: 3.42–15.00). Allergic diseases predicted
Uncontrolled, severe asthma subtype membership with
an odds ratio of 1.84 (1.03–3.28).
Table 3 Best fitting posterior probabilities in each class in the crude and adjusted models
Crude model (adjusted for gendera and age only) Adjusted model
Mean (minimum value – maximum value) Mean (minimum value – maximum value)
The whole population
Fully controlled, Mild asthma 0.64 (0.35–0.95) 0.82 (0.37–1.00)
Partly Controlled, Mild asthma 0.83 (0.36–1.00) 0.83 (0.43–1.00)
Partly controlled, Moderate asthma 0.77 (0.42–1.00) 0.77 (0.35–1.00)
Uncontrolled asthma, Unknown severity 0.79 (0.42–1.00) 0.83 (0.31–1.00)
Uncontrolled, Severe asthma 0.77 (0.34–0.96) 0.71 (0.36–0.99)
No. (%) of people below 0.50 187 (9.37) 108 (5.76)
Women
Controlled, Mild asthma 0.74 (0.37–1.00) 0.79 (0.34–1.00)
Partly controlled, Moderate asthma 0.85 (0.39–1.00) 0.88 (0.39–1.00)
Uncontrolled asthma, Unknown severity 0.88 (0.41–1.00) 0.81 (0.39–1.00)
Uncontrolled, Severe asthma 0.88 (0.39–1.00) 0.88 (0.45–1.00)
No. (%) of people below 0.50 37 (2.84) 53 (4.31)
Men
Controlled, Mild asthma 0.81 (0.53–0.99) 0.90 (0.49–1.00)
Uncontrolled asthma, Unknown severity 0.81 (0.50–1.00) 0.82 (0.44–1.00)
Partly controlled, Severe asthma 0.90 (0.40–1.00) 0.92 (0.40–1.00)
No. (%) of people below 0.50 1 (0.14) 10 (1.55)
aGender not adjusted for in the subtype analyses of women and men
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Among men, identifying separate predictors for Partly
controlled, severe asthma and Uncontrolled asthma with
unknown severity was difficult, as almost all factors pre-
dicted belonging to these subtypes with similar odds ratios
(Table 4). The only exception to this trend was that those
who reported having allergic diseases showed a higher
odds ratio for belonging to the Partly controlled, severe
asthma subtype (1.67, 0.94–2.96) compared to the Uncon-
trolled asthma with unknown severity subtype (0.93, 0.54–
1.62). COPD was a significant predictor for both Poorly
controlled asthma with unknown severity and Partly con-
trolled, severe asthma subtypes with the corresponding
odds ratios of 9.01 (4.35–18.66) and 9.57 (4.62–19.83).
When adjusting for all covariates, the best posterior
probabilities calculated among men and women were el-
evated compared to the non-adjusted model (Table 3).
In this analysis, 53 women (4.31%) and 10 men (1.55%)
had their best posterior probability below 0.50. On the
other hand, the mean best posterior probability for each
asthma subtype improved or remained stable, indicating
that for those assigned to that class, the accuracy was
better, although there were more people wavering be-
tween subtypes (Table 3). This is most likely due to the
fact, that the optimal set of covariates is different be-
tween men and women.
Discussion
This population-based cross-sectional study provides evi-
dence that identifying clinically meaningful subtypes of
asthma based on questionnaire data is possible. The classi-
fication above benefits clinical work, because it provides a
simpler way of categorizing asthmatics without using
complicated clinical measurements. We performed the
subtype analyses among women and men separately and
found that gender-specific analysis is essential when asses-
sing asthma control and severity. We also show that by
calculating the class membership probability, the results
of latent class analyses become easier to interpret and
apply, because each individual patient can now be placed
to one of the subtypes. We found high posterior probabil-
ities which show that most individuals fit well into their
respective subtype. This method, although quite inform-
ative, has to our knowledge been applied in only one
previous study on asthma subtypes [10].
The finding that, especially among men, there is a
large group of asthmatics with insufficient use of medi-
cation and healthcare services is worrying, and it calls
for better patient-education programs. It is noticeable
that among women higher age predicts the risk of un-
controlled asthma, but that it is also linked to poorer
use of medical services. Thus, older age seems to create
a difficulty when assessing the severity of asthma among
women. Obese people were more likely to belong to the
subtypes of asthma with severe disease and poor asthma
control among both women and men. Among men, pre-
dictors separating subtypes of severe manifestations and
those of unknown severity could not be identified. How-
ever, concomitant COPD was linked with severe mani-
festations of asthma, irrespective of the asthma subtype.
For clinical work it is important to recognize the sub-
types at risk of poorer asthma management since it
might be possible to regain better control of their dis-
ease and thus prevent future complications of poorly
managed disease [23, 24].
Validity of results
The previous studies that have applied similar type of
analysis methods, have included factors for classification
that were a mixture of etiological factors, outcomes of
asthma, characteristics of individuals, and presence of
atopic manifestations [1–12]. In this study, we included
in the subtype analyses only factors that are related to
the manifestations or treatment of asthma. Thus, our ap-
proach provides a new alternative method for identifying
subtypes of asthma that is more easily applicable for
clinical work, especially in primary care settings with
limited resources. The strengths of our study include the
fact that asthma diagnosis was based on registry data re-
ceived from the Social Insurance Institution of Finland.
The criteria that they require for warranting the reim-
bursement right for asthma medication are clearly
defined in Finland and follow the criteria recommended
by the national asthma program report [35, 36]. Thus,
the diagnosis of asthma was accurate and consistent
between different asthma patients in this study. The
questionnaires were distributed by The Social Insurance
Institution of Finland. This was because, under the
current law, the investigators are not allowed to contact
directly asthmatics identified through this registry. This
explains why the response rate (40%) was satisfactory,
but lower than in our other epidemiologic studies [37,
38]. We have many subjects (26% in women and 53% in
men) whose asthma severity is defined as “unknown”.
This is mainly a question of labelling. We could have
called this subtype moderate severity, but since the ATS/
ERS guidelines require assessment of asthma severity
under “adequate treatment” [25], we cannot fully assess
the severity of their asthma, as this group does not seem
to use all the treatments that are available. Introduction
of some degree of information bias due to over-
reporting of symptoms is possible in this study.
However, a bias would be introduced only if such over-
reporting would be related to the determinants of the
subtype that the individual belongs to.
We did not verify the subtypes with full scale lung func-
tion testing and were not able to verify the results in an-
other population due to the uniqueness of this data
collection, these questions remain for future studies. This
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is also the situation often faced in clinical work, especially
in primary care, as well as in large epidemiologic studies.
We also did not have the possibility to test the population
for biomarkers and form endotypes out of this population,
which would be the next step towards investigating
whether these subtypes might influence asthma treatment
in the future [39]. It is however highly likely, that behind
the observed subtypes there are underlying mechanisms,
for example inflammation that at least partly would ex-
plain the differences in asthma control and severity [39].
Synthesis with previous knowledge
As the choice of the variables applied in our study is in
many ways different compared to previous studies that
have applied similar type of analysis methods, a com-
parison between the results is difficult [1–12]. However,
we did identify some subtypes that are similar to those
found in other populations. For example, our subtype
Uncontrolled, Severe asthma among women is compar-
able to groups called “severe” or “difficult-to treat”
asthma in some previous studies [1, 4]. However, we did
not find such subtype among men, as in no class was
the asthma-related medication or health-care use as ex-
tensive as among women belonging to this class. In
addition, our subtype of Controlled, mild asthma is
comparable to the one called “inactive/mild untreated
adult onset asthma” in previous studies [4]. According
to our literature review, no previous study has examined
asthma subtypes among men and women separately in
stratified analyses. According to our findings this is an
essential feature in the analyses, since especially the as-
sessment of asthma severity seems to differ substantially
between the genders in clinical practice.
We included potential determinants of class member-
ship, i.e. asthma subtype, in our analyses, such as COPD
[21], allergic diseases [20], age [22], and obesity [19]. In
our study, all of these predicted membership of subtypes
with poor control and increased severity. However, the
posterior probability of the best-fitting class did not im-
prove after adding these covariates, which indicates that
the optimal set of covariates may differ between men
and women.
Conclusions
This population-based cross-sectional study provides evi-
dence that adult asthma can be classified into subtypes ac-
cording to the level of asthma control and asthma severity
based on questionnaire-derived variables. We identified
asthma subtypes separately among men and women which
was crucial for the accuracy of the classification. We used
latent class analyses to subtype asthmatics. In addition, we
identified several predictors for subtypes that are character-
ized by poor asthma control and severe disease. We applied
the capacity of LCA to estimate an individual’s probability
to belong to the formed subtype of asthma. Our results
show that most individuals can be placed accurately into
the subtypes identified. In the future, such subtyping may
facilitate treatment of asthma patients in primary care.
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